NCT02361541View on ClinicalTrials.gov

Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia

CompletedOBSERVATIONAL
Enrollment

3,045

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Hepatitis CHIV
Interventions
PROCEDURE

HCV screening

HCV antibody screening, liver function tests, full blood count and HbsAg will performed. Additional blood samples will be taken for further HCV diagnostic work-out (polymerase chain reaction (PCR) and genotyping). For patients with current HCV infection, liver ultrasound, transient elastography - Firbroscan and further lab analysis will be performed.

Trial Locations (1)

Unknown

Sihanouk Hospital Center of HOPE (SHCH), Cambodia, Phnom Penh

All Listed Sponsors
collaborator

Sihanouk Hospital Center of HOPE (SHCH), Phnom Penh, Cambodia

UNKNOWN

collaborator

Universiteit Antwerpen

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT02361541 - Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia | Biotech Hunter | Biotech Hunter